Revance Therapeutics Faces Investigation by Law Firm
The Law Offices of Frank R. Cruz is currently investigating Revance Therapeutics, Inc. (RVNC) due to potential breaches of federal securities laws. This investigation is initiated on behalf of shareholders who may have incurred losses.
Understanding the Legal Concerns
Investors need to be aware that Revance recently disclosed in a filing with the U.S. Securities and Exchange Commission significant issues regarding its exclusive distribution arrangement with Teoxane SA. The company has received a notice demanding remedies for alleged major breaches related to buffer stock levels and efforts to market Teoxane products.
Impact of Recent Developments on Share Price
In light of these circumstances, Revance’s stock experienced a notable decline. On the day of this disclosure, the stock price decreased by $0.44, accounting for a 7.66% drop, closing at $5.365 per share. This downward shift has raised concerns among investors about the company's stability and the overall impact on their investments.
Investor Communication and Resources
The law firm encourages any shareholder who suffered losses to reach out for more information or to participate in the potential claims. Contacting Frank R. Cruz directly could provide insights into what steps to take next, ensuring that investors understand their rights.
How to Stay Informed
To stay updated on this evolving story, investors are invited to follow the law firm's updates on various platforms, including social media. Staying informed can be crucial in times of uncertainty, allowing investors to make educated decisions.
Contact Information for Concerns
If you have interest in following up on this investigation or have pertinent information, please contact The Law Offices of Frank R. Cruz. Their office is located at 2121 Avenue of the Stars, Suite 800, Century City, California 90067. You can reach them at 310-914-5007 or via email at info@frankcruzlaw.com.
Guidance for Affected Investors
Investors who have purchased Revance securities are encouraged to assess their positions. The potential for legal recourse may be available, and those affected should explore their options with qualified legal counsel to ensure their interests are protected.
Frequently Asked Questions
What is the investigation about?
The investigation concerns potential violations of federal securities laws by Revance Therapeutics related to their distribution agreement with Teoxane SA.
Why did the stock price fall?
The stock price fell due to the disclosure of significant issues with their distribution agreement, leading to investor concerns and selling pressure.
How can I participate in the claims?
Affected shareholders can contact The Law Offices of Frank R. Cruz to learn about how to participate in the claims related to the investigation.
What should I do if I suffered losses?
If you suffered financial losses with Revance securities, consider reaching out to legal counsel for guidance on potential recourse available to you.
Where can I find more updates on the situation?
Investors can follow The Law Offices of Frank R. Cruz on social media and their official website for the latest developments regarding this investigation.
